chr9-135714582-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020822.3(KCNT1):​c.116C>T​(p.Pro39Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00551 in 1,355,446 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 34 hom. )

Consequence

KCNT1
NM_020822.3 missense

Scores

2
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.169
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033433735).
BP6
Variant 9-135714582-C-T is Benign according to our data. Variant chr9-135714582-C-T is described in ClinVar as [Benign]. Clinvar id is 129351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135714582-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00389 (581/149260) while in subpopulation NFE AF= 0.00618 (414/66988). AF 95% confidence interval is 0.00569. There are 0 homozygotes in gnomad4. There are 272 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 581 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KCNT1NM_020822.3 linkuse as main transcriptc.116C>T p.Pro39Leu missense_variant 2/31 ENST00000371757.7
KCNT1XM_011518878.4 linkuse as main transcriptc.251C>T p.Pro84Leu missense_variant 2/31
KCNT1XM_011518879.4 linkuse as main transcriptc.251C>T p.Pro84Leu missense_variant 2/31
KCNT1NM_001272003.2 linkuse as main transcriptc.110+12214C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KCNT1ENST00000371757.7 linkuse as main transcriptc.116C>T p.Pro39Leu missense_variant 2/311 NM_020822.3 A2Q5JUK3-3

Frequencies

GnomAD3 genomes
AF:
0.00389
AC:
580
AN:
149156
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00105
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.00200
Gnomad ASJ
AF:
0.00613
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00309
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00616
Gnomad OTH
AF:
0.00587
GnomAD3 exomes
AF:
0.00413
AC:
582
AN:
140822
Hom.:
6
AF XY:
0.00434
AC XY:
352
AN XY:
81098
show subpopulations
Gnomad AFR exome
AF:
0.000662
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00605
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00110
Gnomad FIN exome
AF:
0.00397
Gnomad NFE exome
AF:
0.00660
Gnomad OTH exome
AF:
0.00345
GnomAD4 exome
AF:
0.00571
AC:
6886
AN:
1206186
Hom.:
34
Cov.:
30
AF XY:
0.00573
AC XY:
3421
AN XY:
597264
show subpopulations
Gnomad4 AFR exome
AF:
0.000870
Gnomad4 AMR exome
AF:
0.00132
Gnomad4 ASJ exome
AF:
0.00833
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00125
Gnomad4 FIN exome
AF:
0.00435
Gnomad4 NFE exome
AF:
0.00640
Gnomad4 OTH exome
AF:
0.00538
GnomAD4 genome
AF:
0.00389
AC:
581
AN:
149260
Hom.:
0
Cov.:
32
AF XY:
0.00373
AC XY:
272
AN XY:
72848
show subpopulations
Gnomad4 AFR
AF:
0.00104
Gnomad4 AMR
AF:
0.00200
Gnomad4 ASJ
AF:
0.00613
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00248
Gnomad4 FIN
AF:
0.00309
Gnomad4 NFE
AF:
0.00618
Gnomad4 OTH
AF:
0.00580
Alfa
AF:
0.00625
Hom.:
0
Bravo
AF:
0.00396
ESP6500AA
AF:
0.00123
AC:
5
ESP6500EA
AF:
0.00504
AC:
41
ExAC
AF:
0.00366
AC:
425

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxFeb 11, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 07, 2016- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 07, 2014- -
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 05, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
KCNT1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 03, 2024This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Developmental and epileptic encephalopathy, 14 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024KCNT1: BS1, BS2 -
Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
15
DANN
Benign
0.96
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0017
N
LIST_S2
Benign
0.58
T;T
MetaRNN
Benign
0.0033
T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.3
.;N
REVEL
Benign
0.029
Sift
Benign
0.087
.;T
Sift4G
Uncertain
0.012
D;D
Vest4
0.15
MVP
0.067
MPC
0.64
ClinPred
0.0061
T
GERP RS
-0.47
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201051863; hg19: chr9-138606428; API